Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5 -- Ignore unavailable to you. Want to Upgrade?

To: GARY P GROBBEL who wrote (44011)	12/2/2005 12:31:00 PM
From: rrufff	Read Replies (1) \| Respond to of 120415

APNO 1.34 x 1.35 for fans of tiny float, low promoted prospects. This is the former XTRN which was r/s 1/10. At some point, this is going to be promoted. It drifted down close to a dollar on very light volume and has just shifted direction with light volume. The spread hsa been narrowed from the .10-.20 it was before. O/S is under 10 million Alpha Innotech had revenues of $10.5 million for the fiscal year ended December 31, 2004, and expects revenues to increase at least 15% for the year ending December 31, 2005, as compared to the prior year. So that’s $16 million. If you read the fairness opinion and filings in connection with the merger, you see that the company was valued perhaps at least 2x current price and, in fact, was selling as high as $3 range pre split. The XTRN insiders could have liquidated and cashed out with over the equivalent of about $2.50 so they must feel that this is worth more than that. About Alpha Innotech Founded in 1992, Alpha Innotech Corporation develops, manufactures and markets digital imaging and detection systems for the Life Science research and Drug Discovery markets. Our goal is to combine instruments, reagents and bioinformatics software to offer integrated modular technology platforms for functional genomics, proteomics and cell analysis markets. Our customers include pharmaceutical and biotechnology companies as well as universities, medical centers, government research institutes and agencies worldwide. Our products address two segments of the life science research market. Gel Documentation: Our digital imaging system for gel documentation are used to detect, archive, and analyze fluorescent, chemiluminescent and visible samples such as DNA, proteins and bacterial colonies. In addition, we offer a full range of software and reagents to complement our detection systems, including a 21 CFR Part 11 compliant software package. MicroArray/Multiplexed Arrays: Our new products address the growing microarray applications market which includes a multiplexed arrays technology platform (few targets—many samples) for high throughput analysis of DNA, protein and cell arrays in microplates and on other substrates. The multiplexed array platform can be used for a number of applications including high throughput screening, diagnostics, personalized medicine and biosurveillance. Our goal is to be a total solutions provider by bringing easy to use and cost effective solutions in gel documentation and array systems to the broader scientific community. Flexibility in all of our platforms allows us to address multiple applications in the emerging molecular and systems biology marketplace. Alpha Innotech At-A-Glance Market Alpha Innotech Corporation is a provider of innovative integrated discovery products for life sciences research and drug discovery markets with core expertise in quantitative imaging, informatics, and molecular biology. Alpha Innotech has over 30 thousands users of our products worldwide. Our products are sold in 35 plus countries. History Alpha Innotech was founded in 1992. In 2001, Alpha Innotech raised its first round of funding to fuel rapid growth into the functional genomics, proteomics and cell analysis marketplace by offering integrated hardware, software and informatics tools. Important Dates 1992 • Alpha Innotech Corporation founded • Launched first product, the IS 1000 gel documentation system 1995 • Launched FA-1000 portable emission microscope 1996 • Launched AlphaImager gel documentation system and AlphaEase software platform 1997 • Launched ChemiImager chemiluminescence imaging system 1998 • Launched AlphaScan scanning densitometer • Launched SpectraImager color microscopy imaging system • Launched AlphaMatch 1D & AlphaMatch 2D software 1999 • Launched FluorChem; fluorescence imaging system • Launched FA-2000 Emission Microscope 2000 • Launched ChemiGlow reagent kit 2001 • AlphaDigiDoc digital documentation system • Launched Falcon Emission Microscope • Closed first-round expansion funding 2002 • Launched the AlphaImager 3400; fluorescent imaging system • Released AlphaArray 7000 High Throughput Microarray Reader on early-access basis • Released AlphaEaseFC v3.1.2 Imaging Software; integrating all systems to a single software platform and Windows 2000 compatibility • Launched AlphaDigiDoc 1200 digital documentation system with leading performance specifications 2003 • Launched AlphaDigiDoc 1201 digital documentation system upgrade • Released AlphaArray 7000MPS Microplate Microarray Reader on early-access basis • Launched FluorChem 9900 High Resolution Imaging System with leading sensitivity and resolution 2004 • Launched AlphaDigiDoc RT • Launched AlphaImager, AlphaImager HP, AlphaImager EC • Launched FluorChem, FluorChem CP, FluorChem SP, and FluorChem HD 2005 • Introduced AlphaPart11Ease software for 21 CFR Part 11 compliance • Launched AlphaQuant Molecular Ladders • Introduced microarray product line: NovaRay microplate scanner, AlphaScan Laser-based slide scanner